Kelsey Klein

Ketamine for the treatment of major depressive disorder and bipolar depression: A review of the literature.

Mental Health Clinician January 2017 Sarah E Grady, Travis A Marsh, Allison Tenhouse et al.

Over the past decade, ketamine has been studied for major depressive disorder and bipolar depression. Ketamine is believed to exert its antidepressant properties through N-methyl-D-aspartate receptor antagonism. Study authors completed a literature review of seven randomized controlled trials of ketamine usage in major depressive disorder and bipolar depression. Ketamine demonstrated a...